Summary
Further key aspects of the report indicate that:
Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary.
The global Advanced Infusion Systems market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for @@@@@ are the significant development of demand and improvement of COVID-19 and geo-economics.
Based on the type of product, the global Advanced Infusion Systems market segmented into
Disposable Infusion System
Elastomeric Infusion System
Ambulatory Infusion System
Volumetric Infusion System
Patient Controlled Analgesia Pump
Syringe Infusion System
Implantable Infusion System.
Based on the end-use, the global Advanced Infusion Systems market classified into
Hospitals
Ambulatory Surgical Centers
Diagnostic Centers.
Based on geography, the global Advanced Infusion Systems market segmented into
North America [U.S., Canada, Mexico]
Europe [Germany, UK, France, Italy, Rest of Europe]
Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]
South America [Brazil, Argentina, Rest of Latin America]
Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]
And the major players included in the report are
AngioDynamics, Inc
Medtronic, Inc
Terumo Corporation
Johnson & Johnson
CareFusion Corporation
Animas Corporation
Baxter International, Inc
B. Braun Melsungen AG
Further key aspects of the report indicate that:
Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary.
The global Advanced Infusion Systems market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for @@@@@ are the significant development of demand and improvement of COVID-19 and geo-economics.
Based on the type of product, the global Advanced Infusion Systems market segmented into
Disposable Infusion System
Elastomeric Infusion System
Ambulatory Infusion System
Volumetric Infusion System
Patient Controlled Analgesia Pump
Syringe Infusion System
Implantable Infusion System.
Based on the end-use, the global Advanced Infusion Systems market classified into
Hospitals
Ambulatory Surgical Centers
Diagnostic Centers.
Based on geography, the global Advanced Infusion Systems market segmented into
North America [U.S., Canada, Mexico]
Europe [Germany, UK, France, Italy, Rest of Europe]
Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]
South America [Brazil, Argentina, Rest of Latin America]
Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]
And the major players included in the report are
AngioDynamics, Inc
Medtronic, Inc
Terumo Corporation
Johnson & Johnson
CareFusion Corporation
Animas Corporation
Baxter International, Inc
B. Braun Melsungen AG
Table of Contents
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL ADVANCED INFUSION SYSTEMS INDUSTRY
2.1 Summary about Advanced Infusion Systems Industry
2.2 Advanced Infusion Systems Market Trends
2.2.1 Advanced Infusion Systems Production & Consumption Trends
2.2.2 Advanced Infusion Systems Demand Structure Trends
2.3 Advanced Infusion Systems Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Disposable Infusion System
4.2.2 Elastomeric Infusion System
4.2.3 Ambulatory Infusion System
4.2.4 Volumetric Infusion System
4.2.5 Patient Controlled Analgesia Pump
4.2.6 Syringe Infusion System
4.2.7 Implantable Infusion System.
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Hospitals
4.3.2 Ambulatory Surgical Centers
4.3.3 Diagnostic Centers.
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Disposable Infusion System
5.2.2 Elastomeric Infusion System
5.2.3 Ambulatory Infusion System
5.2.4 Volumetric Infusion System
5.2.5 Patient Controlled Analgesia Pump
5.2.6 Syringe Infusion System
5.2.7 Implantable Infusion System.
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Hospitals
5.3.2 Ambulatory Surgical Centers
5.3.3 Diagnostic Centers.
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Disposable Infusion System
6.2.2 Elastomeric Infusion System
6.2.3 Ambulatory Infusion System
6.2.4 Volumetric Infusion System
6.2.5 Patient Controlled Analgesia Pump
6.2.6 Syringe Infusion System
6.2.7 Implantable Infusion System.
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Hospitals
6.3.2 Ambulatory Surgical Centers
6.3.3 Diagnostic Centers.
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Disposable Infusion System
7.2.2 Elastomeric Infusion System
7.2.3 Ambulatory Infusion System
7.2.4 Volumetric Infusion System
7.2.5 Patient Controlled Analgesia Pump
7.2.6 Syringe Infusion System
7.2.7 Implantable Infusion System.
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Hospitals
7.3.2 Ambulatory Surgical Centers
7.3.3 Diagnostic Centers.
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Disposable Infusion System
8.2.2 Elastomeric Infusion System
8.2.3 Ambulatory Infusion System
8.2.4 Volumetric Infusion System
8.2.5 Patient Controlled Analgesia Pump
8.2.6 Syringe Infusion System
8.2.7 Implantable Infusion System.
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Hospitals
8.3.2 Ambulatory Surgical Centers
8.3.3 Diagnostic Centers.
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Disposable Infusion System
9.2.2 Elastomeric Infusion System
9.2.3 Ambulatory Infusion System
9.2.4 Volumetric Infusion System
9.2.5 Patient Controlled Analgesia Pump
9.2.6 Syringe Infusion System
9.2.7 Implantable Infusion System.
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Hospitals
9.3.2 Ambulatory Surgical Centers
9.3.3 Diagnostic Centers.
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 AngioDynamics, Inc
10.1.2 Medtronic, Inc
10.1.3 Terumo Corporation
10.1.4 Johnson & Johnson
10.1.5 CareFusion Corporation
10.1.6 Animas Corporation
10.1.7 Baxter International, Inc
10.1.8 B. Braun Melsungen AG
10.2 Advanced Infusion Systems Sales Date of Major Players (2017-2020e)
10.2.1 AngioDynamics, Inc
10.2.2 Medtronic, Inc
10.2.3 Terumo Corporation
10.2.4 Johnson & Johnson
10.2.5 CareFusion Corporation
10.2.6 Animas Corporation
10.2.7 Baxter International, Inc
10.2.8 B. Braun Melsungen AG
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL ADVANCED INFUSION SYSTEMS INDUSTRY
2.1 Summary about Advanced Infusion Systems Industry
2.2 Advanced Infusion Systems Market Trends
2.2.1 Advanced Infusion Systems Production & Consumption Trends
2.2.2 Advanced Infusion Systems Demand Structure Trends
2.3 Advanced Infusion Systems Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Disposable Infusion System
4.2.2 Elastomeric Infusion System
4.2.3 Ambulatory Infusion System
4.2.4 Volumetric Infusion System
4.2.5 Patient Controlled Analgesia Pump
4.2.6 Syringe Infusion System
4.2.7 Implantable Infusion System.
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Hospitals
4.3.2 Ambulatory Surgical Centers
4.3.3 Diagnostic Centers.
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Disposable Infusion System
5.2.2 Elastomeric Infusion System
5.2.3 Ambulatory Infusion System
5.2.4 Volumetric Infusion System
5.2.5 Patient Controlled Analgesia Pump
5.2.6 Syringe Infusion System
5.2.7 Implantable Infusion System.
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Hospitals
5.3.2 Ambulatory Surgical Centers
5.3.3 Diagnostic Centers.
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Disposable Infusion System
6.2.2 Elastomeric Infusion System
6.2.3 Ambulatory Infusion System
6.2.4 Volumetric Infusion System
6.2.5 Patient Controlled Analgesia Pump
6.2.6 Syringe Infusion System
6.2.7 Implantable Infusion System.
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Hospitals
6.3.2 Ambulatory Surgical Centers
6.3.3 Diagnostic Centers.
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Disposable Infusion System
7.2.2 Elastomeric Infusion System
7.2.3 Ambulatory Infusion System
7.2.4 Volumetric Infusion System
7.2.5 Patient Controlled Analgesia Pump
7.2.6 Syringe Infusion System
7.2.7 Implantable Infusion System.
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Hospitals
7.3.2 Ambulatory Surgical Centers
7.3.3 Diagnostic Centers.
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Disposable Infusion System
8.2.2 Elastomeric Infusion System
8.2.3 Ambulatory Infusion System
8.2.4 Volumetric Infusion System
8.2.5 Patient Controlled Analgesia Pump
8.2.6 Syringe Infusion System
8.2.7 Implantable Infusion System.
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Hospitals
8.3.2 Ambulatory Surgical Centers
8.3.3 Diagnostic Centers.
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Disposable Infusion System
9.2.2 Elastomeric Infusion System
9.2.3 Ambulatory Infusion System
9.2.4 Volumetric Infusion System
9.2.5 Patient Controlled Analgesia Pump
9.2.6 Syringe Infusion System
9.2.7 Implantable Infusion System.
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Hospitals
9.3.2 Ambulatory Surgical Centers
9.3.3 Diagnostic Centers.
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 AngioDynamics, Inc
10.1.2 Medtronic, Inc
10.1.3 Terumo Corporation
10.1.4 Johnson & Johnson
10.1.5 CareFusion Corporation
10.1.6 Animas Corporation
10.1.7 Baxter International, Inc
10.1.8 B. Braun Melsungen AG
10.2 Advanced Infusion Systems Sales Date of Major Players (2017-2020e)
10.2.1 AngioDynamics, Inc
10.2.2 Medtronic, Inc
10.2.3 Terumo Corporation
10.2.4 Johnson & Johnson
10.2.5 CareFusion Corporation
10.2.6 Animas Corporation
10.2.7 Baxter International, Inc
10.2.8 B. Braun Melsungen AG
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT
